NORFLOXACIN FOR THE PROPHYLAXIS OF TRAVELERS DIARRHEA IN UNITED-STATES MILITARY PERSONNEL

被引：46

作者：

SCOTT, DA

HABERBERGER, RL

THORNTON, SA

HYAMS, KC

机构：

[1] USN,MED RES UNIT 3,CAIRO,EGYPT

[2] USN,MED RES INST,BETHESDA,MD 20814

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 1990年 / 42卷 / 02期

关键词：

D O I：

10.4269/ajtmh.1990.42.160

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Norfloxacin, an oral fluoroquinolone (dose 400 mg daily), was compared to a placebo in a double blinded randomized trial for the prophylaxis of travelers' diarrhea. The study was of U.S. Navy and Marine Corps personnel on shore leave in Alexandria, Egypt. A total of 222 subjects were available (105 norfloxacin, 117 placebo). In the placebo group, 26% (30/117) developed acute diarrhea vs. 2% (2/105) in the norfloxacin group. There were no significant side effects in either group.

引用

页码：160 / 164

页数：5

共 19 条

[1] BLASER MJ, 1986, REV INFECT DIS, V8, pS142
[2] DUPONT HL, 1986, REV INFECT DIS, V8, pS167
[3] PREVENTION OF TRAVELERS DIARRHEA BY THE TABLET FORMULATION OF BISMUTH SUBSALICYLATE
DUPONT, HL
ERICSSON, CD
JOHNSON, PC
BITSURA, JAM
DUPONT, MW
DELACABADA, FJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (10): : 1347 - 1350
[4] LACK OF EMERGENCE OF RESISTANT FECAL FLORA DURING SUCCESSFUL PROPHYLAXIS OF TRAVELERS DIARRHEA WITH NORFLOXACIN
JOHNSON, PC
ERICSSON, CD
MORGAN, DR
DUPONT, HL
CABADA, FJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) : 671 - 674
[5] A NEWLY RECOGNIZED CAUSE OF TRAVELERS DIARRHEA - ENTEROADHERENT ESCHERICHIA-COLI
MATHEWSON, JJ
JOHNSON, PC
DUPONT, HL
MORGAN, DR
THORNTON, SA
WOOD, LV
ERICSSON, CD
[J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) : 471 - 475
[6] MICROBIOLOGIC AND CLINICAL-STUDY OF ACUTE DIARRHEA IN CHILDREN IN ASWAN, EGYPT
MIKHAIL, IA
HYAMS, KC
PODGORE, JK
HABERBERGER, RL
BOGHDADI, AM
MANSOUR, NS
WOODY, JN
[J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (01) : 59 - 65
[7] MUNSHI MH, 1987, LANCET, V2, P419
[8] Neu H C, 1988, Rev Infect Dis, V10 Suppl 1, pS57
[9] OHARE MD, 1985, DRUG EXP CLIN RES, V11, P253
[10] SACK RB, 1986, REV INFECT DIS, V8, pS160

← 1 2 →